Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.4821
Delayed Data
As of Mar 22
 -0.0189 / -3.77%
Today’s Change
0.33
Today|||52-Week Range
1.42
-3.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues29.9M27.1M18.2M5.1M
 
 
 
 
 
Depreciation And Amortization227.0K223.0K244.0K188.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses65.0M56.6M36.7M23.5M
 
 
 
 
 
Research And Development55.3M46.2M25.1M14.8M
 
 
 
 
 
Total Operating Expenses65.2M56.8M36.9M23.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.3M-29.7M-18.8M-18.7M
 
 
 
 
 
Extraordinary Credit3.2M4.0M1.9M2.1M
 
 
 
 
 
Extraordinary Charge0.00-531.0K0.00-3.8M
 
 
 
Other Expenses120.0K-19.0K-64.0K-13.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.8M-26.2M-16.8M-20.1M
 
 
 
 
 
Net Income-31.8M-26.2M-16.8M-20.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M18.1M26.1M29.9M
 
 
 
 
 
Shares To Calculate EPS Diluted14.7M18.1M26.1M29.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.17-$1.45-$0.64-$0.67
 
 
 
 
 
EPS Diluted-$2.17-$1.45-$0.64-$0.67